KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 83 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $3,289,000 | -94.3% | 43,870 | -94.3% | 0.00% | -93.8% |
| Q2 2015 | $58,159,000 | +59.1% | 772,260 | +6.0% | 0.05% | +60.0% |
| Q1 2015 | $36,545,000 | +145.8% | 728,704 | +70.0% | 0.03% | +150.0% |
| Q4 2014 | $14,867,000 | -5.3% | 428,694 | -10.6% | 0.01% | -7.7% |
| Q3 2014 | $15,702,000 | -17.6% | 479,311 | -3.5% | 0.01% | -18.8% |
| Q2 2014 | $19,061,000 | -6.4% | 496,779 | -3.0% | 0.02% | -11.1% |
| Q1 2014 | $20,359,000 | +10.0% | 512,038 | +3.1% | 0.02% | +5.9% |
| Q4 2013 | $18,505,000 | +997.6% | 496,768 | +1246.2% | 0.02% | +750.0% |
| Q3 2013 | $1,686,000 | +1016.6% | 36,902 | +561.8% | 0.00% | – |
| Q2 2013 | $151,000 | – | 5,576 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 33,271 | $1,277,000 | 4.55% |
| Palo Alto Investors LP | 949,959 | $36,450,000 | 2.71% |
| Redmile Group, LLC | 560,356 | $21,501,000 | 2.61% |
| SENZAR ASSET MANAGEMENT, LLC | 124,900 | $4,792,000 | 1.83% |
| Aureus Asset Management, LLC | 152,662 | $5,858,000 | 1.46% |
| PFM Health Sciences, LP | 952,715 | $36,556,000 | 0.73% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $6,771,000 | 0.63% |
| Polar Capital LLP | 519,398 | $19,927,000 | 0.42% |
| FNY Managed Accounts LLC | 2,500 | $95,925,000 | 0.35% |
| Partner Investment Management, L.P. | 36,173 | $1,388,000 | 0.28% |